NN6 Fundamental Analysis - NANOREPRO AG

Fundamental Rating

We assign a fundamental rating of 5 out of 10 to NN6. NN6 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for NN6 as it has an excellent financial health rating, but there are worries on the profitability. NN6 shows excellent growth, but is valued quite expensive already.

Quickly go to:

1. Profitability

1.1 Basic Checks

NN6 had negative earnings in the past year.

In multiple years NN6 reported negative net income over the last 5 years.

In multiple years NN6 reported negative operating cash flow during the last 5 years.

1.2 Ratios

NN6 has a worse Return On Assets (-4.53%) than 67.69% of its industry peers.

Looking at the Return On Equity, with a value of -4.65%, NN6 is doing worse than 67.69% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-4.53%
ROE	-4.65%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of NN6 (59.26%) is comparable to the rest of the industry.

NN6's Gross Margin has declined in the last couple of years.

NN6 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	59.26%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y21.24%

GM growth 5Y-10.7%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NN6 does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for NN6 remains at a similar level compared to 1 year ago.

Compared to 5 years ago, NN6 has more shares outstanding

There is no outstanding debt for NN6. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 17.25 indicates that NN6 is not in any danger for bankruptcy at the moment.

NN6 has a better Altman-Z score (17.25) than 98.46% of its industry peers.

NN6 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	17.25

ROIC/WACCN/A

WACC7.3%

2.3 Liquidity

A Current Ratio of 32.26 indicates that NN6 has no problem at all paying its short term obligations.

NN6 has a Current ratio of 32.26. This is amongst the best in the industry. NN6 outperforms 100.00% of its industry peers.

A Quick Ratio of 30.32 indicates that NN6 has no problem at all paying its short term obligations.

NN6 has a Quick ratio of 30.32. This is amongst the best in the industry. NN6 outperforms 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	32.26
Quick Ratio	30.32

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NN6 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.13%, which is quite impressive.

Looking at the last year, NN6 shows a very strong growth in Revenue. The Revenue has grown by 44.10%.

The Revenue has been growing by 29.69% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)39.13%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%22.22%

Revenue 1Y (TTM)44.1%

Revenue growth 3Y-69.83%

Revenue growth 5Y29.69%

Sales Q2Q%37.29%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 104.40% on average over the next years. This is a very strong growth

EPS Next Y-1%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year232.82%

Revenue Next 2Y104.4%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NN6 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NN6's earnings are expected to grow with 41.42% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.98%, NN6 is a good candidate for dividend investing.

Compared to an average industry Dividend Yield of 1.11, NN6 pays a better dividend. On top of this NN6 pays more dividend than 100.00% of the companies listed in the same industry.

Compared to an average S&P500 Dividend Yield of 2.00, NN6 pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	6.98%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DPN/A

EPS Next 2Y41.42%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NANOREPRO AG

FRA:NN6 (12/23/2025, 7:00:00 PM)

1.51

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners9.02%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap19.48M

Revenue(TTM)5.13M

Net Income(TTM)-1.72M

Analysts84

Price Target4.59 (203.97%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	6.98%

Yearly Dividend0.15

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	3.8
P/FCF	N/A
P/OCF	N/A
P/B	0.52
P/tB	0.57
EV/EBITDA	N/A

EPS(TTM)-0.14

EYN/A

EPS(NY)0

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.4

BVpS2.89

TBVpS2.63

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-4.53%
ROE	-4.65%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	59.26%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y21.24%

GM growth 5Y-10.7%

F-ScoreN/A

Asset Turnover0.14

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	32.26
Quick Ratio	30.32
Altman-Z	17.25

F-ScoreN/A

WACC7.3%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.13%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%22.22%

EPS Next Y-1%

EPS Next 2Y41.42%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)44.1%

Revenue growth 3Y-69.83%

Revenue growth 5Y29.69%

Sales Q2Q%37.29%

Revenue Next Year232.82%

Revenue Next 2Y104.4%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y49.69%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year38.06%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y195%

FCF growth 3Y4.97%

FCF growth 5YN/A

OCF growth 1Y198.6%

OCF growth 3Y6.28%

OCF growth 5YN/A

NANOREPRO AG / NN6.DE FAQ

What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE.

What is the valuation status for NN6 stock?

ChartMill assigns a valuation rating of 1 / 10 to NANOREPRO AG (NN6.DE). This can be considered as Overvalued.

What is the profitability of NN6 stock?

NANOREPRO AG (NN6.DE) has a profitability rating of 1 / 10.

Can you provide the financial health for NN6 stock?

The financial health rating of NANOREPRO AG (NN6.DE) is 9 / 10.

NANOREPRO AG (NN6.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

NANOREPRO AG / NN6.DE FAQ

What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?

What is the valuation status for NN6 stock?

What is the profitability of NN6 stock?

Can you provide the financial health for NN6 stock?